nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—HTR7—Parkinson's disease	0.129	0.179	CbGaD
Olanzapine—DRD3—Parkinson's disease	0.121	0.169	CbGaD
Olanzapine—DRD1—Parkinson's disease	0.119	0.166	CbGaD
Olanzapine—HTR1A—Parkinson's disease	0.0989	0.138	CbGaD
Olanzapine—DRD2—Parkinson's disease	0.084	0.117	CbGaD
Olanzapine—HTR2A—Parkinson's disease	0.0649	0.0902	CbGaD
Olanzapine—CYP2D6—Parkinson's disease	0.0593	0.0825	CbGaD
Olanzapine—ABCB1—Parkinson's disease	0.0424	0.0589	CbGaD
Olanzapine—DRD3—telencephalic ventricle—Parkinson's disease	0.00235	0.0223	CbGeAlD
Olanzapine—HTR7—locus ceruleus—Parkinson's disease	0.00222	0.021	CbGeAlD
Olanzapine—HTR2A—enteric nervous system—Parkinson's disease	0.0021	0.0198	CbGeAlD
Olanzapine—HTR5A—forebrain—Parkinson's disease	0.00177	0.0167	CbGeAlD
Olanzapine—HTR7—sympathetic nervous system—Parkinson's disease	0.00176	0.0166	CbGeAlD
Olanzapine—DRD1—telencephalic ventricle—Parkinson's disease	0.00168	0.0159	CbGeAlD
Olanzapine—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00159	0.015	CbGeAlD
Olanzapine—HTR2A—locus ceruleus—Parkinson's disease	0.00138	0.0131	CbGeAlD
Olanzapine—HTR1B—telencephalic ventricle—Parkinson's disease	0.00137	0.0129	CbGeAlD
Olanzapine—HTR1D—telencephalic ventricle—Parkinson's disease	0.00132	0.0125	CbGeAlD
Olanzapine—HTR2C—telencephalic ventricle—Parkinson's disease	0.00131	0.0124	CbGeAlD
Olanzapine—HTR7—pons—Parkinson's disease	0.00128	0.0121	CbGeAlD
Olanzapine—HTR7—autonomic nervous system—Parkinson's disease	0.00118	0.0112	CbGeAlD
Olanzapine—HTR2A—cerebellar cortex—Parkinson's disease	0.00113	0.0107	CbGeAlD
Olanzapine—HTR1A—telencephalic ventricle—Parkinson's disease	0.0011	0.0104	CbGeAlD
Olanzapine—HTR2A—sympathetic nervous system—Parkinson's disease	0.00109	0.0104	CbGeAlD
Olanzapine—DRD1—nerve—Parkinson's disease	0.00106	0.01	CbGeAlD
Olanzapine—HTR7—telencephalic ventricle—Parkinson's disease	0.00105	0.00996	CbGeAlD
Olanzapine—HTR3A—nerve—Parkinson's disease	0.00103	0.0097	CbGeAlD
Olanzapine—HTR5A—head—Parkinson's disease	0.00101	0.00956	CbGeAlD
Olanzapine—DRD2—telencephalic ventricle—Parkinson's disease	0.000995	0.00942	CbGeAlD
Olanzapine—HTR5A—nervous system—Parkinson's disease	0.000959	0.00907	CbGeAlD
Olanzapine—HTR5A—central nervous system—Parkinson's disease	0.000923	0.00873	CbGeAlD
Olanzapine—HTR7—peripheral nervous system—Parkinson's disease	0.000851	0.00805	CbGeAlD
Olanzapine—HTR2A—pons—Parkinson's disease	0.000798	0.00755	CbGeAlD
Olanzapine—HTR1E—brainstem—Parkinson's disease	0.000781	0.00739	CbGeAlD
Olanzapine—HTR1E—forebrain—Parkinson's disease	0.000754	0.00713	CbGeAlD
Olanzapine—HTR2A—autonomic nervous system—Parkinson's disease	0.000736	0.00696	CbGeAlD
Olanzapine—HTR5A—brain—Parkinson's disease	0.000733	0.00693	CbGeAlD
Olanzapine—HTR7—nerve—Parkinson's disease	0.000664	0.00628	CbGeAlD
Olanzapine—HTR2A—telencephalic ventricle—Parkinson's disease	0.000657	0.00621	CbGeAlD
Olanzapine—DRD2—nerve—Parkinson's disease	0.000627	0.00593	CbGeAlD
Olanzapine—ADRA2A—peripheral nervous system—Parkinson's disease	0.000624	0.00591	CbGeAlD
Olanzapine—HTR6—forebrain—Parkinson's disease	0.000591	0.00559	CbGeAlD
Olanzapine—DRD5—forebrain—Parkinson's disease	0.000576	0.00545	CbGeAlD
Olanzapine—HTR2A—peripheral nervous system—Parkinson's disease	0.000531	0.00502	CbGeAlD
Olanzapine—HTR1A—hindbrain—Parkinson's disease	0.00052	0.00492	CbGeAlD
Olanzapine—H1F0—embryo—Parkinson's disease	0.000504	0.00477	CbGeAlD
Olanzapine—HTR7—hindbrain—Parkinson's disease	0.000497	0.0047	CbGeAlD
Olanzapine—ADRA1A—hindbrain—Parkinson's disease	0.000479	0.00453	CbGeAlD
Olanzapine—DRD2—hindbrain—Parkinson's disease	0.00047	0.00445	CbGeAlD
Olanzapine—HRH2—cardiovascular system—Parkinson's disease	0.000457	0.00433	CbGeAlD
Olanzapine—DRD1—brainstem—Parkinson's disease	0.000456	0.00431	CbGeAlD
Olanzapine—H1F0—forebrain—Parkinson's disease	0.000446	0.00421	CbGeAlD
Olanzapine—HTR3A—brainstem—Parkinson's disease	0.00044	0.00416	CbGeAlD
Olanzapine—DRD1—forebrain—Parkinson's disease	0.00044	0.00416	CbGeAlD
Olanzapine—HTR1E—head—Parkinson's disease	0.000432	0.00408	CbGeAlD
Olanzapine—HTR3A—forebrain—Parkinson's disease	0.000425	0.00402	CbGeAlD
Olanzapine—HTR2A—nerve—Parkinson's disease	0.000414	0.00391	CbGeAlD
Olanzapine—HTR1E—nervous system—Parkinson's disease	0.000409	0.00387	CbGeAlD
Olanzapine—HTR1E—central nervous system—Parkinson's disease	0.000394	0.00373	CbGeAlD
Olanzapine—CHRM4—head—Parkinson's disease	0.000378	0.00358	CbGeAlD
Olanzapine—H1F0—cardiovascular system—Parkinson's disease	0.000377	0.00356	CbGeAlD
Olanzapine—HTR1B—brainstem—Parkinson's disease	0.000369	0.00349	CbGeAlD
Olanzapine—DRD4—brain—Parkinson's disease	0.000363	0.00343	CbGeAlD
Olanzapine—CHRM4—nervous system—Parkinson's disease	0.000359	0.00339	CbGeAlD
Olanzapine—HTR1D—brainstem—Parkinson's disease	0.000358	0.00338	CbGeAlD
Olanzapine—HTR1B—forebrain—Parkinson's disease	0.000357	0.00337	CbGeAlD
Olanzapine—CHRM2—forebrain—Parkinson's disease	0.000355	0.00335	CbGeAlD
Olanzapine—HTR2C—brainstem—Parkinson's disease	0.000354	0.00335	CbGeAlD
Olanzapine—DRD3—head—Parkinson's disease	0.000352	0.00333	CbGeAlD
Olanzapine—FMO3—head—Parkinson's disease	0.000348	0.00329	CbGeAlD
Olanzapine—CHRM4—central nervous system—Parkinson's disease	0.000345	0.00327	CbGeAlD
Olanzapine—HTR1D—forebrain—Parkinson's disease	0.000345	0.00326	CbGeAlD
Olanzapine—HTR2C—forebrain—Parkinson's disease	0.000342	0.00323	CbGeAlD
Olanzapine—HTR6—head—Parkinson's disease	0.000339	0.0032	CbGeAlD
Olanzapine—DRD3—nervous system—Parkinson's disease	0.000334	0.00316	CbGeAlD
Olanzapine—FMO3—nervous system—Parkinson's disease	0.00033	0.00312	CbGeAlD
Olanzapine—DRD5—head—Parkinson's disease	0.00033	0.00312	CbGeAlD
Olanzapine—CHRM1—forebrain—Parkinson's disease	0.000323	0.00305	CbGeAlD
Olanzapine—H1F0—medulla oblongata—Parkinson's disease	0.000322	0.00305	CbGeAlD
Olanzapine—DRD3—central nervous system—Parkinson's disease	0.000321	0.00304	CbGeAlD
Olanzapine—HTR6—nervous system—Parkinson's disease	0.000321	0.00304	CbGeAlD
Olanzapine—HTR2B—forebrain—Parkinson's disease	0.000321	0.00304	CbGeAlD
Olanzapine—FMO3—central nervous system—Parkinson's disease	0.000318	0.003	CbGeAlD
Olanzapine—HTR1E—brain—Parkinson's disease	0.000313	0.00296	CbGeAlD
Olanzapine—DRD5—nervous system—Parkinson's disease	0.000313	0.00296	CbGeAlD
Olanzapine—HTR2A—hindbrain—Parkinson's disease	0.00031	0.00293	CbGeAlD
Olanzapine—HRH2—head—Parkinson's disease	0.00031	0.00293	CbGeAlD
Olanzapine—HTR6—central nervous system—Parkinson's disease	0.000309	0.00292	CbGeAlD
Olanzapine—HTR1B—cardiovascular system—Parkinson's disease	0.000301	0.00285	CbGeAlD
Olanzapine—DRD5—central nervous system—Parkinson's disease	0.000301	0.00285	CbGeAlD
Olanzapine—CHRM2—cardiovascular system—Parkinson's disease	0.0003	0.00284	CbGeAlD
Olanzapine—HTR1A—brainstem—Parkinson's disease	0.000298	0.00282	CbGeAlD
Olanzapine—CHRM5—head—Parkinson's disease	0.000296	0.0028	CbGeAlD
Olanzapine—H1F0—midbrain—Parkinson's disease	0.000294	0.00278	CbGeAlD
Olanzapine—HRH2—nervous system—Parkinson's disease	0.000294	0.00278	CbGeAlD
Olanzapine—Amoxapine—HTR7—Parkinson's disease	0.000293	0.0531	CrCbGaD
Olanzapine—HTR1D—cardiovascular system—Parkinson's disease	0.000292	0.00276	CbGeAlD
Olanzapine—DRD1—midbrain—Parkinson's disease	0.000291	0.00275	CbGeAlD
Olanzapine—CHRM3—forebrain—Parkinson's disease	0.000289	0.00273	CbGeAlD
Olanzapine—HTR1A—forebrain—Parkinson's disease	0.000288	0.00272	CbGeAlD
Olanzapine—H1F0—spinal cord—Parkinson's disease	0.000287	0.00272	CbGeAlD
Olanzapine—HTR7—brainstem—Parkinson's disease	0.000285	0.00269	CbGeAlD
Olanzapine—HRH2—central nervous system—Parkinson's disease	0.000283	0.00267	CbGeAlD
Olanzapine—CYP2D6—hindbrain—Parkinson's disease	0.000282	0.00267	CbGeAlD
Olanzapine—CHRM5—nervous system—Parkinson's disease	0.00028	0.00265	CbGeAlD
Olanzapine—Amoxapine—DRD3—Parkinson's disease	0.000276	0.0499	CrCbGaD
Olanzapine—HTR7—forebrain—Parkinson's disease	0.000275	0.0026	CbGeAlD
Olanzapine—ADRA1A—brainstem—Parkinson's disease	0.000275	0.0026	CbGeAlD
Olanzapine—CHRM4—brain—Parkinson's disease	0.000274	0.00259	CbGeAlD
Olanzapine—CHRM1—cardiovascular system—Parkinson's disease	0.000273	0.00258	CbGeAlD
Olanzapine—HTR2B—cardiovascular system—Parkinson's disease	0.000272	0.00257	CbGeAlD
Olanzapine—Amoxapine—DRD1—Parkinson's disease	0.000271	0.049	CrCbGaD
Olanzapine—ADRA1B—head—Parkinson's disease	0.00027	0.00256	CbGeAlD
Olanzapine—CHRM5—central nervous system—Parkinson's disease	0.00027	0.00255	CbGeAlD
Olanzapine—DRD2—brainstem—Parkinson's disease	0.000269	0.00255	CbGeAlD
Olanzapine—ADRA1A—forebrain—Parkinson's disease	0.000265	0.00251	CbGeAlD
Olanzapine—DRD2—forebrain—Parkinson's disease	0.00026	0.00246	CbGeAlD
Olanzapine—Amoxapine—SLC6A3—Parkinson's disease	0.000256	0.0464	CrCbGaD
Olanzapine—ADRA1B—nervous system—Parkinson's disease	0.000256	0.00242	CbGeAlD
Olanzapine—H1F0—head—Parkinson's disease	0.000255	0.00241	CbGeAlD
Olanzapine—DRD3—brain—Parkinson's disease	0.000255	0.00241	CbGeAlD
Olanzapine—FMO3—brain—Parkinson's disease	0.000252	0.00238	CbGeAlD
Olanzapine—DRD1—head—Parkinson's disease	0.000252	0.00238	CbGeAlD
Olanzapine—HTR2C—medulla oblongata—Parkinson's disease	0.000247	0.00234	CbGeAlD
Olanzapine—ADRA1B—central nervous system—Parkinson's disease	0.000247	0.00233	CbGeAlD
Olanzapine—HTR6—brain—Parkinson's disease	0.000245	0.00232	CbGeAlD
Olanzapine—ORM1—spinal cord—Parkinson's disease	0.000245	0.00232	CbGeAlD
Olanzapine—HTR3A—head—Parkinson's disease	0.000243	0.0023	CbGeAlD
Olanzapine—HTR1A—cardiovascular system—Parkinson's disease	0.000243	0.0023	CbGeAlD
Olanzapine—H1F0—nervous system—Parkinson's disease	0.000242	0.00229	CbGeAlD
Olanzapine—DRD5—brain—Parkinson's disease	0.000239	0.00226	CbGeAlD
Olanzapine—DRD1—nervous system—Parkinson's disease	0.000239	0.00226	CbGeAlD
Olanzapine—HTR1B—midbrain—Parkinson's disease	0.000235	0.00223	CbGeAlD
Olanzapine—H1F0—central nervous system—Parkinson's disease	0.000233	0.0022	CbGeAlD
Olanzapine—HTR7—cardiovascular system—Parkinson's disease	0.000232	0.0022	CbGeAlD
Olanzapine—HTR3A—nervous system—Parkinson's disease	0.000231	0.00218	CbGeAlD
Olanzapine—DRD1—central nervous system—Parkinson's disease	0.00023	0.00218	CbGeAlD
Olanzapine—HTR1B—spinal cord—Parkinson's disease	0.00023	0.00217	CbGeAlD
Olanzapine—Loxapine—HTR7—Parkinson's disease	0.000229	0.0414	CrCbGaD
Olanzapine—HTR1D—midbrain—Parkinson's disease	0.000228	0.00216	CbGeAlD
Olanzapine—H1F0—cerebellum—Parkinson's disease	0.000228	0.00215	CbGeAlD
Olanzapine—HTR2C—midbrain—Parkinson's disease	0.000226	0.00213	CbGeAlD
Olanzapine—Amoxapine—HTR1A—Parkinson's disease	0.000225	0.0407	CrCbGaD
Olanzapine—HRH2—brain—Parkinson's disease	0.000224	0.00212	CbGeAlD
Olanzapine—ADRA1A—cardiovascular system—Parkinson's disease	0.000224	0.00212	CbGeAlD
Olanzapine—Quetiapine—HTR7—Parkinson's disease	0.000223	0.0404	CrCbGaD
Olanzapine—HTR3A—central nervous system—Parkinson's disease	0.000222	0.0021	CbGeAlD
Olanzapine—HTR2C—spinal cord—Parkinson's disease	0.00022	0.00208	CbGeAlD
Olanzapine—Loxapine—DRD3—Parkinson's disease	0.000215	0.039	CrCbGaD
Olanzapine—CHRM5—brain—Parkinson's disease	0.000214	0.00203	CbGeAlD
Olanzapine—Loxapine—DRD1—Parkinson's disease	0.000211	0.0382	CrCbGaD
Olanzapine—Quetiapine—DRD3—Parkinson's disease	0.00021	0.038	CrCbGaD
Olanzapine—ORM1—nervous system—Parkinson's disease	0.000206	0.00195	CbGeAlD
Olanzapine—Quetiapine—DRD1—Parkinson's disease	0.000206	0.0373	CrCbGaD
Olanzapine—HRH1—forebrain—Parkinson's disease	0.000205	0.00194	CbGeAlD
Olanzapine—HTR1B—head—Parkinson's disease	0.000204	0.00193	CbGeAlD
Olanzapine—CHRM2—head—Parkinson's disease	0.000203	0.00192	CbGeAlD
Olanzapine—ADRA2A—forebrain—Parkinson's disease	0.000202	0.00191	CbGeAlD
Olanzapine—Loxapine—SLC6A3—Parkinson's disease	0.0002	0.0363	CrCbGaD
Olanzapine—ORM1—central nervous system—Parkinson's disease	0.000199	0.00188	CbGeAlD
Olanzapine—HTR7—medulla oblongata—Parkinson's disease	0.000199	0.00188	CbGeAlD
Olanzapine—HTR1D—head—Parkinson's disease	0.000198	0.00187	CbGeAlD
Olanzapine—ADRA1B—brain—Parkinson's disease	0.000196	0.00185	CbGeAlD
Olanzapine—HTR2C—head—Parkinson's disease	0.000196	0.00185	CbGeAlD
Olanzapine—HTR2A—embryo—Parkinson's disease	0.000194	0.00183	CbGeAlD
Olanzapine—HTR1B—nervous system—Parkinson's disease	0.000194	0.00183	CbGeAlD
Olanzapine—CHRM2—nervous system—Parkinson's disease	0.000193	0.00182	CbGeAlD
Olanzapine—Clozapine—HTR7—Parkinson's disease	0.000192	0.0348	CrCbGaD
Olanzapine—Amoxapine—DRD2—Parkinson's disease	0.000191	0.0345	CrCbGaD
Olanzapine—HTR1A—midbrain—Parkinson's disease	0.00019	0.0018	CbGeAlD
Olanzapine—HTR1D—nervous system—Parkinson's disease	0.000187	0.00177	CbGeAlD
Olanzapine—HTR1B—central nervous system—Parkinson's disease	0.000186	0.00176	CbGeAlD
Olanzapine—HTR2C—nervous system—Parkinson's disease	0.000186	0.00176	CbGeAlD
Olanzapine—HTR1A—spinal cord—Parkinson's disease	0.000185	0.00175	CbGeAlD
Olanzapine—CHRM2—central nervous system—Parkinson's disease	0.000185	0.00175	CbGeAlD
Olanzapine—H1F0—brain—Parkinson's disease	0.000185	0.00175	CbGeAlD
Olanzapine—CHRM1—head—Parkinson's disease	0.000185	0.00175	CbGeAlD
Olanzapine—HTR2B—head—Parkinson's disease	0.000184	0.00174	CbGeAlD
Olanzapine—ADRA2C—medulla oblongata—Parkinson's disease	0.000183	0.00173	CbGeAlD
Olanzapine—DRD1—brain—Parkinson's disease	0.000183	0.00173	CbGeAlD
Olanzapine—HTR7—midbrain—Parkinson's disease	0.000182	0.00172	CbGeAlD
Olanzapine—Clozapine—DRD3—Parkinson's disease	0.000181	0.0327	CrCbGaD
Olanzapine—HTR1D—central nervous system—Parkinson's disease	0.00018	0.00171	CbGeAlD
Olanzapine—HTR2C—central nervous system—Parkinson's disease	0.000179	0.00169	CbGeAlD
Olanzapine—HTR2A—brainstem—Parkinson's disease	0.000178	0.00168	CbGeAlD
Olanzapine—Clozapine—DRD1—Parkinson's disease	0.000177	0.0321	CrCbGaD
Olanzapine—HTR7—spinal cord—Parkinson's disease	0.000177	0.00168	CbGeAlD
Olanzapine—HTR3A—brain—Parkinson's disease	0.000176	0.00167	CbGeAlD
Olanzapine—CYP2C9—cardiovascular system—Parkinson's disease	0.000176	0.00166	CbGeAlD
Olanzapine—Loxapine—HTR1A—Parkinson's disease	0.000175	0.0318	CrCbGaD
Olanzapine—CHRM1—nervous system—Parkinson's disease	0.000175	0.00166	CbGeAlD
Olanzapine—HTR2B—nervous system—Parkinson's disease	0.000174	0.00165	CbGeAlD
Olanzapine—DRD2—midbrain—Parkinson's disease	0.000172	0.00162	CbGeAlD
Olanzapine—HTR2A—forebrain—Parkinson's disease	0.000171	0.00162	CbGeAlD
Olanzapine—Quetiapine—HTR1A—Parkinson's disease	0.000171	0.031	CrCbGaD
Olanzapine—CHRM1—central nervous system—Parkinson's disease	0.000169	0.0016	CbGeAlD
Olanzapine—HTR2B—central nervous system—Parkinson's disease	0.000168	0.00159	CbGeAlD
Olanzapine—ADRA2C—midbrain—Parkinson's disease	0.000167	0.00158	CbGeAlD
Olanzapine—CHRM3—head—Parkinson's disease	0.000165	0.00156	CbGeAlD
Olanzapine—HTR1A—head—Parkinson's disease	0.000165	0.00156	CbGeAlD
Olanzapine—ADRA2C—spinal cord—Parkinson's disease	0.000163	0.00154	CbGeAlD
Olanzapine—CYP2D6—brainstem—Parkinson's disease	0.000162	0.00153	CbGeAlD
Olanzapine—HTR7—head—Parkinson's disease	0.000157	0.00149	CbGeAlD
Olanzapine—CHRM3—nervous system—Parkinson's disease	0.000157	0.00148	CbGeAlD
Olanzapine—CYP2D6—forebrain—Parkinson's disease	0.000156	0.00148	CbGeAlD
Olanzapine—HTR1A—nervous system—Parkinson's disease	0.000156	0.00148	CbGeAlD
Olanzapine—ADRA1A—head—Parkinson's disease	0.000152	0.00144	CbGeAlD
Olanzapine—CHRM3—central nervous system—Parkinson's disease	0.000151	0.00143	CbGeAlD
Olanzapine—HTR1A—central nervous system—Parkinson's disease	0.00015	0.00142	CbGeAlD
Olanzapine—HTR7—nervous system—Parkinson's disease	0.000149	0.00141	CbGeAlD
Olanzapine—Loxapine—DRD2—Parkinson's disease	0.000149	0.027	CrCbGaD
Olanzapine—DRD2—head—Parkinson's disease	0.000149	0.00141	CbGeAlD
Olanzapine—HTR1B—brain—Parkinson's disease	0.000148	0.0014	CbGeAlD
Olanzapine—Amoxapine—HTR2A—Parkinson's disease	0.000147	0.0267	CrCbGaD
Olanzapine—Clozapine—HTR1A—Parkinson's disease	0.000147	0.0267	CrCbGaD
Olanzapine—CHRM2—brain—Parkinson's disease	0.000147	0.00139	CbGeAlD
Olanzapine—HTR1A—cerebellum—Parkinson's disease	0.000147	0.00139	CbGeAlD
Olanzapine—ADRA2A—medulla oblongata—Parkinson's disease	0.000146	0.00138	CbGeAlD
Olanzapine—Quetiapine—DRD2—Parkinson's disease	0.000145	0.0263	CrCbGaD
Olanzapine—HTR2A—cardiovascular system—Parkinson's disease	0.000145	0.00137	CbGeAlD
Olanzapine—ADRA2C—head—Parkinson's disease	0.000145	0.00137	CbGeAlD
Olanzapine—ADRA1A—nervous system—Parkinson's disease	0.000144	0.00136	CbGeAlD
Olanzapine—HTR7—central nervous system—Parkinson's disease	0.000144	0.00136	CbGeAlD
Olanzapine—HTR1D—brain—Parkinson's disease	0.000143	0.00135	CbGeAlD
Olanzapine—HTR2C—brain—Parkinson's disease	0.000142	0.00134	CbGeAlD
Olanzapine—DRD2—nervous system—Parkinson's disease	0.000141	0.00133	CbGeAlD
Olanzapine—HTR7—cerebellum—Parkinson's disease	0.00014	0.00133	CbGeAlD
Olanzapine—ADRA1A—central nervous system—Parkinson's disease	0.000139	0.00131	CbGeAlD
Olanzapine—ALB—brain—Parkinson's disease	0.000138	0.00131	CbGeAlD
Olanzapine—ADRA2C—nervous system—Parkinson's disease	0.000137	0.0013	CbGeAlD
Olanzapine—DRD2—central nervous system—Parkinson's disease	0.000136	0.00129	CbGeAlD
Olanzapine—ADRA1A—cerebellum—Parkinson's disease	0.000135	0.00128	CbGeAlD
Olanzapine—Amoxapine—CYP2D6—Parkinson's disease	0.000135	0.0244	CrCbGaD
Olanzapine—CHRM1—brain—Parkinson's disease	0.000134	0.00127	CbGeAlD
Olanzapine—HTR2B—brain—Parkinson's disease	0.000133	0.00126	CbGeAlD
Olanzapine—ADRA2A—midbrain—Parkinson's disease	0.000133	0.00126	CbGeAlD
Olanzapine—DRD2—cerebellum—Parkinson's disease	0.000133	0.00126	CbGeAlD
Olanzapine—ADRA2C—central nervous system—Parkinson's disease	0.000132	0.00125	CbGeAlD
Olanzapine—ADRA2A—spinal cord—Parkinson's disease	0.00013	0.00123	CbGeAlD
Olanzapine—ADRA2C—cerebellum—Parkinson's disease	0.000129	0.00122	CbGeAlD
Olanzapine—ABCB1—embryo—Parkinson's disease	0.000127	0.0012	CbGeAlD
Olanzapine—Clozapine—DRD2—Parkinson's disease	0.000125	0.0226	CrCbGaD
Olanzapine—HTR2A—medulla oblongata—Parkinson's disease	0.000124	0.00117	CbGeAlD
Olanzapine—Clozapine—CYP2E1—Parkinson's disease	0.00012	0.0218	CrCbGaD
Olanzapine—CHRM3—brain—Parkinson's disease	0.00012	0.00113	CbGeAlD
Olanzapine—HTR1A—brain—Parkinson's disease	0.000119	0.00113	CbGeAlD
Olanzapine—HRH1—head—Parkinson's disease	0.000118	0.00111	CbGeAlD
Olanzapine—ADRA2A—head—Parkinson's disease	0.000115	0.00109	CbGeAlD
Olanzapine—Loxapine—HTR2A—Parkinson's disease	0.000115	0.0208	CrCbGaD
Olanzapine—HTR7—brain—Parkinson's disease	0.000114	0.00108	CbGeAlD
Olanzapine—HTR2A—midbrain—Parkinson's disease	0.000113	0.00107	CbGeAlD
Olanzapine—ABCB1—forebrain—Parkinson's disease	0.000112	0.00106	CbGeAlD
Olanzapine—Quetiapine—HTR2A—Parkinson's disease	0.000112	0.0203	CrCbGaD
Olanzapine—HRH1—nervous system—Parkinson's disease	0.000111	0.00105	CbGeAlD
Olanzapine—HTR2A—spinal cord—Parkinson's disease	0.00011	0.00104	CbGeAlD
Olanzapine—ADRA1A—brain—Parkinson's disease	0.00011	0.00104	CbGeAlD
Olanzapine—ADRA2A—nervous system—Parkinson's disease	0.000109	0.00104	CbGeAlD
Olanzapine—DRD2—brain—Parkinson's disease	0.000108	0.00102	CbGeAlD
Olanzapine—HRH1—central nervous system—Parkinson's disease	0.000107	0.00101	CbGeAlD
Olanzapine—ADRA2A—central nervous system—Parkinson's disease	0.000105	0.000997	CbGeAlD
Olanzapine—ADRA2C—brain—Parkinson's disease	0.000105	0.000992	CbGeAlD
Olanzapine—ADRA2A—cerebellum—Parkinson's disease	0.000103	0.000974	CbGeAlD
Olanzapine—Quetiapine—CYP2D6—Parkinson's disease	0.000103	0.0186	CrCbGaD
Olanzapine—HTR2A—head—Parkinson's disease	9.82e-05	0.000929	CbGeAlD
Olanzapine—Clozapine—HTR2A—Parkinson's disease	9.67e-05	0.0175	CrCbGaD
Olanzapine—ABCB1—cardiovascular system—Parkinson's disease	9.5e-05	0.000899	CbGeAlD
Olanzapine—HTR2A—nervous system—Parkinson's disease	9.31e-05	0.00088	CbGeAlD
Olanzapine—HTR2A—central nervous system—Parkinson's disease	8.96e-05	0.000848	CbGeAlD
Olanzapine—CYP2D6—head—Parkinson's disease	8.94e-05	0.000846	CbGeAlD
Olanzapine—Clozapine—CYP2D6—Parkinson's disease	8.84e-05	0.016	CrCbGaD
Olanzapine—HTR2A—cerebellum—Parkinson's disease	8.76e-05	0.000828	CbGeAlD
Olanzapine—CYP3A4—nervous system—Parkinson's disease	8.62e-05	0.000815	CbGeAlD
Olanzapine—HRH1—brain—Parkinson's disease	8.52e-05	0.000806	CbGeAlD
Olanzapine—CYP2D6—nervous system—Parkinson's disease	8.48e-05	0.000802	CbGeAlD
Olanzapine—ADRA2A—brain—Parkinson's disease	8.37e-05	0.000791	CbGeAlD
Olanzapine—CYP3A4—central nervous system—Parkinson's disease	8.3e-05	0.000785	CbGeAlD
Olanzapine—CYP2D6—central nervous system—Parkinson's disease	8.16e-05	0.000772	CbGeAlD
Olanzapine—ABCB1—medulla oblongata—Parkinson's disease	8.12e-05	0.000768	CbGeAlD
Olanzapine—CYP2D6—cerebellum—Parkinson's disease	7.98e-05	0.000755	CbGeAlD
Olanzapine—ABCB1—midbrain—Parkinson's disease	7.42e-05	0.000702	CbGeAlD
Olanzapine—Quetiapine—ABCB1—Parkinson's disease	7.34e-05	0.0133	CrCbGaD
Olanzapine—ABCB1—spinal cord—Parkinson's disease	7.24e-05	0.000685	CbGeAlD
Olanzapine—HTR2A—brain—Parkinson's disease	7.11e-05	0.000673	CbGeAlD
Olanzapine—CYP2D6—brain—Parkinson's disease	6.48e-05	0.000613	CbGeAlD
Olanzapine—ABCB1—head—Parkinson's disease	6.43e-05	0.000609	CbGeAlD
Olanzapine—Clozapine—ABCB1—Parkinson's disease	6.31e-05	0.0114	CrCbGaD
Olanzapine—ABCB1—nervous system—Parkinson's disease	6.1e-05	0.000577	CbGeAlD
Olanzapine—ABCB1—central nervous system—Parkinson's disease	5.87e-05	0.000555	CbGeAlD
Olanzapine—ABCB1—cerebellum—Parkinson's disease	5.74e-05	0.000543	CbGeAlD
Olanzapine—ABCB1—brain—Parkinson's disease	4.66e-05	0.000441	CbGeAlD
Olanzapine—ABCB1—Metabolism—CYP2E1—Parkinson's disease	3.15e-06	1.86e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—HTR2A—Parkinson's disease	3.14e-06	1.86e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—TH—Parkinson's disease	3.14e-06	1.85e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	3.14e-06	1.85e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—APOE—Parkinson's disease	3.13e-06	1.85e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—NQO1—Parkinson's disease	3.11e-06	1.84e-05	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—MAPK8—Parkinson's disease	3.11e-06	1.84e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—HTR2A—Parkinson's disease	3.1e-06	1.83e-05	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—APOE—Parkinson's disease	3.1e-06	1.83e-05	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—MAPK8—Parkinson's disease	3.09e-06	1.82e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—TH—Parkinson's disease	3.07e-06	1.81e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IGF2—Parkinson's disease	3.06e-06	1.8e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—MTHFR—Parkinson's disease	3.05e-06	1.8e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—APOE—Parkinson's disease	3.02e-06	1.78e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—CYCS—Parkinson's disease	3.02e-06	1.78e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—APOE—Parkinson's disease	3.01e-06	1.77e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—INS—Parkinson's disease	3e-06	1.77e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—NGF—Parkinson's disease	3e-06	1.77e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—INS—Parkinson's disease	2.99e-06	1.76e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—COMT—Parkinson's disease	2.98e-06	1.76e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.97e-06	1.75e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—GSTP1—Parkinson's disease	2.96e-06	1.75e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—INS—Parkinson's disease	2.96e-06	1.75e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—MAOA—Parkinson's disease	2.96e-06	1.74e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IGF1R—Parkinson's disease	2.96e-06	1.74e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—NGF—Parkinson's disease	2.95e-06	1.74e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—CYCS—Parkinson's disease	2.95e-06	1.74e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—NGF—Parkinson's disease	2.94e-06	1.74e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	2.94e-06	1.74e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.93e-06	1.73e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—NGF—Parkinson's disease	2.93e-06	1.73e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—NGF—Parkinson's disease	2.92e-06	1.72e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—APOE—Parkinson's disease	2.92e-06	1.72e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—HMOX1—Parkinson's disease	2.92e-06	1.72e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—EDN1—Parkinson's disease	2.92e-06	1.72e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—NQO1—Parkinson's disease	2.91e-06	1.72e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—NGF—Parkinson's disease	2.9e-06	1.71e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—TH—Parkinson's disease	2.89e-06	1.71e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	2.89e-06	1.7e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.88e-06	1.7e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—APOE—Parkinson's disease	2.88e-06	1.7e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—TH—Parkinson's disease	2.87e-06	1.69e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.85e-06	1.68e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	2.85e-06	1.68e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—APOE—Parkinson's disease	2.84e-06	1.68e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—ABCB1—Parkinson's disease	2.81e-06	1.66e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	2.8e-06	1.65e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	2.79e-06	1.65e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	2.78e-06	1.64e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—CYCS—Parkinson's disease	2.78e-06	1.64e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	2.76e-06	1.63e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—CYCS—Parkinson's disease	2.75e-06	1.62e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	2.75e-06	1.62e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	2.75e-06	1.62e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—GSTM1—Parkinson's disease	2.72e-06	1.61e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—CTGF—Parkinson's disease	2.7e-06	1.59e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—NGF—Parkinson's disease	2.68e-06	1.58e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—INS—Parkinson's disease	2.67e-06	1.58e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—COMT—Parkinson's disease	2.67e-06	1.58e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—GSTP1—Parkinson's disease	2.66e-06	1.57e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—MAOA—Parkinson's disease	2.65e-06	1.57e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—APOE—Parkinson's disease	2.65e-06	1.56e-05	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—INS—Parkinson's disease	2.64e-06	1.56e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—HMOX1—Parkinson's disease	2.62e-06	1.55e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—APOE—Parkinson's disease	2.61e-06	1.54e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—COMT—Parkinson's disease	2.61e-06	1.54e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—GPX1—Parkinson's disease	2.61e-06	1.54e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—APOE—Parkinson's disease	2.6e-06	1.54e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—GSTP1—Parkinson's disease	2.6e-06	1.53e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—APOE—Parkinson's disease	2.6e-06	1.53e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—CASP3—Parkinson's disease	2.6e-06	1.53e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—CASP3—Parkinson's disease	2.59e-06	1.53e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—MAOA—Parkinson's disease	2.59e-06	1.53e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—APOE—Parkinson's disease	2.59e-06	1.53e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—INS—Parkinson's disease	2.58e-06	1.52e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling by GPCR—IL6—Parkinson's disease	2.58e-06	1.52e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling by GPCR—IL6—Parkinson's disease	2.58e-06	1.52e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—CASP3—Parkinson's disease	2.58e-06	1.52e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—INS—Parkinson's disease	2.57e-06	1.51e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—APOE—Parkinson's disease	2.56e-06	1.51e-05	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—IL6—Parkinson's disease	2.56e-06	1.51e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—HMOX1—Parkinson's disease	2.56e-06	1.51e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling by GPCR—IL6—Parkinson's disease	2.56e-06	1.51e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	2.56e-06	1.51e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—HTR2A—Parkinson's disease	2.55e-06	1.51e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—CASP3—Parkinson's disease	2.52e-06	1.49e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—ABCB1—Parkinson's disease	2.52e-06	1.49e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	2.51e-06	1.48e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling by GPCR—IL6—Parkinson's disease	2.51e-06	1.48e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—INS—Parkinson's disease	2.5e-06	1.47e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—NQO1—Parkinson's disease	2.49e-06	1.47e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—CASP3—Parkinson's disease	2.48e-06	1.46e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling by GPCR—IL6—Parkinson's disease	2.47e-06	1.45e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—COMT—Parkinson's disease	2.46e-06	1.45e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—INS—Parkinson's disease	2.46e-06	1.45e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—TH—Parkinson's disease	2.45e-06	1.45e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—CASP3—Parkinson's disease	2.45e-06	1.44e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	2.45e-06	1.44e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—GSTM1—Parkinson's disease	2.45e-06	1.44e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—MAOA—Parkinson's disease	2.44e-06	1.44e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—COMT—Parkinson's disease	2.44e-06	1.44e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling by GPCR—IL6—Parkinson's disease	2.43e-06	1.44e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—GSTP1—Parkinson's disease	2.43e-06	1.43e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—INS—Parkinson's disease	2.43e-06	1.43e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—MAOA—Parkinson's disease	2.42e-06	1.43e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	2.41e-06	1.42e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—MTHFR—Parkinson's disease	2.41e-06	1.42e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—HMOX1—Parkinson's disease	2.39e-06	1.41e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—GSTM1—Parkinson's disease	2.39e-06	1.41e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—MAPK8—Parkinson's disease	2.39e-06	1.41e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—MAPK8—Parkinson's disease	2.38e-06	1.41e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—APOE—Parkinson's disease	2.37e-06	1.4e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—CASP3—Parkinson's disease	2.37e-06	1.4e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—MAPK8—Parkinson's disease	2.37e-06	1.4e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling by GPCR—IL6—Parkinson's disease	2.35e-06	1.39e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—CYCS—Parkinson's disease	2.35e-06	1.39e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—CASP3—Parkinson's disease	2.35e-06	1.38e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—GPX1—Parkinson's disease	2.34e-06	1.38e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling by GPCR—IL6—Parkinson's disease	2.33e-06	1.37e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—MAPK8—Parkinson's disease	2.32e-06	1.37e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	2.32e-06	1.37e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—ABCB1—Parkinson's disease	2.3e-06	1.35e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—GPX1—Parkinson's disease	2.29e-06	1.35e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—MAPK8—Parkinson's disease	2.28e-06	1.35e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—INS—Parkinson's disease	2.27e-06	1.34e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—MAPK8—Parkinson's disease	2.25e-06	1.33e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	2.25e-06	1.33e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—APOE—Parkinson's disease	2.24e-06	1.32e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—CASP3—Parkinson's disease	2.23e-06	1.32e-05	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—IL6—Parkinson's disease	2.23e-06	1.32e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—INS—Parkinson's disease	2.23e-06	1.32e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—GSTM1—Parkinson's disease	2.23e-06	1.32e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—INS—Parkinson's disease	2.23e-06	1.31e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling by GPCR—IL6—Parkinson's disease	2.22e-06	1.31e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—INS—Parkinson's disease	2.22e-06	1.31e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—INS—Parkinson's disease	2.21e-06	1.3e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—CASP3—Parkinson's disease	2.21e-06	1.3e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling by GPCR—IL6—Parkinson's disease	2.19e-06	1.29e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—INS—Parkinson's disease	2.19e-06	1.29e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—INS—Parkinson's disease	2.18e-06	1.29e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—MAPK8—Parkinson's disease	2.18e-06	1.28e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—MTHFR—Parkinson's disease	2.16e-06	1.27e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—MAPK8—Parkinson's disease	2.16e-06	1.27e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—GPX1—Parkinson's disease	2.15e-06	1.27e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—GPX1—Parkinson's disease	2.14e-06	1.26e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	2.12e-06	1.25e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—MTHFR—Parkinson's disease	2.11e-06	1.24e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—COMT—Parkinson's disease	2.08e-06	1.23e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CTGF—Parkinson's disease	2.08e-06	1.23e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—GSTP1—Parkinson's disease	2.07e-06	1.22e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—MAOA—Parkinson's disease	2.07e-06	1.22e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—MAPK8—Parkinson's disease	2.05e-06	1.21e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—HMOX1—Parkinson's disease	2.04e-06	1.21e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—INS—Parkinson's disease	2.03e-06	1.2e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—MAPK8—Parkinson's disease	2.03e-06	1.2e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—APOE—Parkinson's disease	2.01e-06	1.19e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—CASP3—Parkinson's disease	1.99e-06	1.17e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.99e-06	1.17e-05	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—IL6—Parkinson's disease	1.99e-06	1.17e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—IL6—Parkinson's disease	1.98e-06	1.17e-05	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—IL6—Parkinson's disease	1.97e-06	1.16e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—MTHFR—Parkinson's disease	1.97e-06	1.16e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—APOE—Parkinson's disease	1.96e-06	1.16e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—ABCB1—Parkinson's disease	1.96e-06	1.16e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.94e-06	1.14e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	1.92e-06	1.13e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.92e-06	1.13e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—INS—Parkinson's disease	1.91e-06	1.13e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	1.91e-06	1.13e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	1.91e-06	1.13e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—GSTM1—Parkinson's disease	1.91e-06	1.12e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	1.9e-06	1.12e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—TH—Parkinson's disease	1.89e-06	1.12e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—CASP3—Parkinson's disease	1.86e-06	1.1e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—APOE—Parkinson's disease	1.85e-06	1.09e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—IL6—Parkinson's disease	1.85e-06	1.09e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—APOE—Parkinson's disease	1.83e-06	1.08e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—CASP3—Parkinson's disease	1.83e-06	1.08e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—MAPK8—Parkinson's disease	1.83e-06	1.08e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—GPX1—Parkinson's disease	1.82e-06	1.08e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—IL6—Parkinson's disease	1.82e-06	1.07e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.82e-06	1.07e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	1.77e-06	1.04e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	1.76e-06	1.04e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—INS—Parkinson's disease	1.72e-06	1.01e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MAPK8—Parkinson's disease	1.71e-06	1.01e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—CASP3—Parkinson's disease	1.69e-06	9.95e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—MTHFR—Parkinson's disease	1.68e-06	9.93e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MAPK8—Parkinson's disease	1.68e-06	9.92e-06	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—INS—Parkinson's disease	1.68e-06	9.9e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—IL6—Parkinson's disease	1.68e-06	9.89e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	1.66e-06	9.79e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CASP3—Parkinson's disease	1.66e-06	9.77e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	1.65e-06	9.74e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	1.65e-06	9.73e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	1.65e-06	9.71e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—IL6—Parkinson's disease	1.65e-06	9.71e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	1.64e-06	9.68e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	1.64e-06	9.65e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	1.63e-06	9.62e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	1.63e-06	9.59e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	1.62e-06	9.55e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	1.62e-06	9.53e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—COMT—Parkinson's disease	1.61e-06	9.48e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.6e-06	9.44e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.6e-06	9.42e-06	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—INS—Parkinson's disease	1.58e-06	9.33e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.58e-06	9.31e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—APOE—Parkinson's disease	1.57e-06	9.25e-06	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—INS—Parkinson's disease	1.57e-06	9.25e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	1.55e-06	9.15e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	1.53e-06	9e-06	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—IL6—Parkinson's disease	1.52e-06	8.99e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	1.52e-06	8.98e-06	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—IL6—Parkinson's disease	1.52e-06	8.98e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	1.52e-06	8.95e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.51e-06	8.94e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	1.51e-06	8.92e-06	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—IL6—Parkinson's disease	1.51e-06	8.92e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CASP3—Parkinson's disease	1.51e-06	8.91e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—IL6—Parkinson's disease	1.5e-06	8.85e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	1.5e-06	8.84e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	1.49e-06	8.81e-06	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—IL6—Parkinson's disease	1.48e-06	8.73e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.47e-06	8.67e-06	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—IL6—Parkinson's disease	1.46e-06	8.59e-06	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—IL6—Parkinson's disease	1.44e-06	8.48e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.41e-06	8.31e-06	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—IL6—Parkinson's disease	1.39e-06	8.2e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MAPK8—Parkinson's disease	1.39e-06	8.19e-06	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—IL6—Parkinson's disease	1.38e-06	8.12e-06	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—INS—Parkinson's disease	1.34e-06	7.9e-06	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—IL6—Parkinson's disease	1.31e-06	7.74e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.3e-06	7.67e-06	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—IL6—Parkinson's disease	1.29e-06	7.63e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—APOE—Parkinson's disease	1.21e-06	7.14e-06	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—IL6—Parkinson's disease	1.17e-06	6.89e-06	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—IL6—Parkinson's disease	1.13e-06	6.65e-06	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—IL6—Parkinson's disease	1.12e-06	6.62e-06	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—IL6—Parkinson's disease	1.09e-06	6.44e-06	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—IL6—Parkinson's disease	1.07e-06	6.34e-06	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—INS—Parkinson's disease	1.03e-06	6.1e-06	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—IL6—Parkinson's disease	9.9e-07	5.84e-06	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—IL6—Parkinson's disease	9.74e-07	5.75e-06	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—IL6—Parkinson's disease	9.72e-07	5.74e-06	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—IL6—Parkinson's disease	9.69e-07	5.72e-06	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—IL6—Parkinson's disease	9.66e-07	5.7e-06	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—IL6—Parkinson's disease	9.57e-07	5.64e-06	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	9.54e-07	5.63e-06	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IL6—Parkinson's disease	8.86e-07	5.23e-06	CbGpPWpGaD
